MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Tissue-engineered nigrostriatal pathway to rebuild dopaminergic axons in Parkinson’s disease based on clinical design criteria

    W. Gordián Vélez, D. Chouhan, H I. Chen, J. Duda, D K. Cullen (Philadelphia, USA)

    Objective: To create a tissue-engineered construct with the dopaminergic (DA) cell numbers, axon lengths, and functionality required to reconstruct the human nigrostriatal pathway (NSP). Background:…
  • MDS Virtual Congress 2021

    Deep brain stimulation for Orthostatic Tremor

    W. Babeliowsky, W. Potter, M. Bot, P. Vanden Munckhof, P. Schuurman, E. Blok, R. de Bie, A. van Rootselaar (Amsterdam, Netherlands)

    Objective: 1) To evaluate the effect of deep brain stimulation (DBS) in Orthostatic Tremor (OT) on standing time and quality of life (QoL), and 2)…
  • MDS Virtual Congress 2021

    Minimum detectable change of an automated algorithm derived spiral analysis parameter

    R. R (Ansarinagar, India)

    Objective: To compute the minimum detectable change (MDC) of an automated algorithm derived spiral analysis parameter for quantification of upper limb action tremor.To compute the…
  • MDS Virtual Congress 2021

    Determining the content of a clinician-rated tool for freezing of gait severity

    A. Scully, B. de Oliveira, K. Hill, D. Tan, YH. Pua, R. Clark, E. Burton (Bentley, Australia)

    Objective: This study aimed to determine clinician’s ratings of the most important triggering circumstances to be examined and aspects of freezing of gait (FOG) to…
  • MDS Virtual Congress 2021

    Acute cerebellar ataxia as a possible post-COVID-19 manifestation – case report

    B. Ciopleiaș, R. Makk, M. Chioașcă, D. Rusu, ș. Diaconu, L. Irincu, C. Falup-Pecurariu (Brasov, Romania)

    Objective: To describe a case report that developed acute cerebellar ataxia a short time after being diagnosed with COVID-19. Background: The COVID-19 infection has a…
  • MDS Virtual Congress 2021

    Role of Uric Acid in Friedreich Ataxia neurodegeneration

    A. Trinchillo, A. de Rosa, F. Saccà (Naples, Italy)

    Objective: Friedreich Ataxia (FRDA) is an inherited recessive disease with reduced frataxin levels. This causes a reduced mitochondrial function and progressive neurodegeneration. The aim of…
  • MDS Virtual Congress 2021

    Progressive and delayed onset hyperglycemic chorea after blood glucose normalization: A case report

    C. Wantaneeyawong, C. Teekaput, K. Booncharoen (Chiang Mai, Thailand)

    Objective: To describe clinical and imaging features of a patient with diabetes mellitus who presented with progressive and delayed onset hyperglycemic chorea which is a…
  • MDS Virtual Congress 2021

    Cognitive-affective syndrome related to cerebellar hypometabolism secondary to Covid-19 infection : a case report

    S. Potel, M. Merceur, P. Méneret, S. Butet, P. Guillemot, G. Silvestre-Beccarel, I. Bonan, F. Le Jeune, M. Vérin (Rennes, France)

    Objective: To describe a novel case of Covid-19-related cognitive affective syndrome with cerebellar hypometabolism and associated neuropathy. Background: Several Covid-19-related neurological diseases have been described, including…
  • MDS Virtual Congress 2021

    A Double Blind, Placebo Controlled, Crossover Study of Incobotulinumtoxin-A in Musician’s Focal Hand Dystonia

    S. Frucht, A. Nmashie, MC. George, C. Wu, A. Pantelyat, E. Altenmüller, M. Chen, D. Feng, DM. Simpson (New York, USA)

    Objective: To determine the safety and efficacy of incobotulinumtoxin-A (BoNT) in musician’s dystonia. Background: Few published trials of BoNT in upper limb task-specific dystonia are…
  • MDS Virtual Congress 2021

    A novel variant [c.2974G>A; (p.Asp992Asp)] of DYT/PARK-ATP1A3

    R. Baviera-Muñoz, M. Campins-Romeu, I. Sastre-Bataller, M. Losada-López, J. Pérez García, E. Novella-Maestre, I. Martinez-Torres (Valencia, Spain)

    Objective: To describe the clinical presentation of a novel likely pathogenic variant in ATP1A3. Background: Rapid onset dystonia-parkinsonism is related to mutations in ATP1A3 gene.…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley